ArticleAdvances in therapy2024

Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy.

Carla Rognoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.